The short answer
Curcumin or turmeric has not been shown to predictably change tramadol absorption or pain relief in people. Animal metabolism findings raise a question, but they do not provide a clinical dose adjustment or spacing rule.
What this answer covers
Isolated curcumin versus Curcuma domestica/longa extracts and food turmeric; formulations and absorption enhancers differ.
- Supplement or preparation
- Curcumin
- Medication ingredient
- tramadol
The direct metabolism experiment was in animals
Rats received curcumin before their isolated livers were perfused with tramadol. Parent-drug and active-metabolite findings varied by schedule. This is not a study of human intestinal absorption, pain relief or a safe supplement dose.
Clinical rescue use does not prove an interaction
A knee-osteoarthritis trial permitted tramadol as rescue treatment during turmeric-extract or ibuprofen therapy. Few patients used it, with no significant between-group difference. The study did not measure how turmeric changed tramadol exposure.
The active metabolite complicates prediction
Tramadol is partly converted by CYP2D6 to active M1. Raising the parent drug while reducing M1 can change opioid and serotonin-related effects differently. An animal enzyme finding cannot predict the net result for a person.
Review concentrated products before changing treatment
Tell the prescriber the actual curcumin product, including any added absorption enhancer. Do not increase tramadol, use a guessed gap or add a supplement to prevent tramadol toxicity. The inspected evidence does not establish these strategies.
Evidence and practical considerations
Absorption & effectiveness
Animal perfusion findings and sparse rescue use in a clinical turmeric trial do not establish human tramadol absorption or net effectiveness changes. Retracted animal toxicity paper excluded; no invented management rule.
- Exact scope
- Isolated curcumin versus Curcuma domestica/longa extracts and food turmeric; formulations and absorption enhancers differ. with Tramadol10689 IN; oral hydrochloride IR/ER with active M1 and formulation limits.
- Medication form and route
- oral medication; oral supplement
What remains uncertain
- No unmeasured pair incidence, blanket class transfer or arbitrary spacing interval.
Factors that may matter: Preparation; Dose; Other medicines; Organ function.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed tramadol
Parent tramadol and active M1 metabolite contribute effects; CYP2D6 inhibition can raise parent while lowering M1. Serotonin syndrome, seizures and CNS-depressant risks.
How this applies: Exact tramadol RxCUI 10689 IN, with stated salt/formulation/route bridge.
Not interchangeable with extended-release dosing or combination products; no botanical-specific incidence.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed tramadol
CYP3A induction including St John’s wort can alter tramadol exposure; serotonergic and CNS-depressant precautions.
How this applies: Exact tramadol RxCUI 10689 IN, with stated salt/formulation/route bridge.
Once-daily formulation-specific directions and restrictions; not an immediate-release or injectable regimen.
Source 3: original animal liver-perfusion experiment
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Small groups of male Wistar rats.
Parent tramadol and M1 profiles differed by treatment schedule; M1 exposure decreased.
How this applies: Isolated animal liver, not human oral absorption or analgesia; text/table direction inconsistencies preclude a simple quantitative prediction.
Isolated animal liver, not human oral absorption or analgesia; text/table direction inconsistencies preclude a simple quantitative prediction.
Source 4: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 367 randomized knee osteoarthritis patients.
No significant difference in proportion using rescue tramadol; few used it.
How this applies: Trial compared treatments for knee OA, not randomized tramadol co-use; no tramadol levels or interaction-specific safety estimate.
Trial compared treatments for knee OA, not randomized tramadol co-use; no tramadol levels or interaction-specific safety estimate.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact tramadol article with formulation-specific evidence and uncertainty. | |
| Research summary published |
Article revision: c1dca18f1d21572d
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.